Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Papaverine use for radial artery sheath entrapment.

Sciahbasi A, Cuono A, Marrangoni A, Rigattieri S.

Anatol J Cardiol. 2019 Jun;22(1):44-45. doi: 10.14744/AnatolJCardiol.2019.71597. No abstract available.

2.

Urinary protein biomarkers in the early detection of lung cancer.

Nolen BM, Lomakin A, Marrangoni A, Velikokhatnaya L, Prosser D, Lokshin AE.

Cancer Prev Res (Phila). 2015 Feb;8(2):111-9. doi: 10.1158/1940-6207.CAPR-14-0210. Epub 2014 Nov 21.

3.

An extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors.

Nolen BM, Orlichenko LS, Marrangoni A, Velikokhatnaya L, Prosser D, Grizzle WE, Ho K, Jenkins FJ, Bovbjerg DH, Lokshin AE.

PLoS One. 2013 May 28;8(5):e63368. doi: 10.1371/journal.pone.0063368. Print 2013.

4.

Circulating prolactin levels and risk of epithelial ovarian cancer.

Clendenen TV, Arslan AA, Lokshin AE, Liu M, Lundin E, Koenig KL, Berrino F, Hallmans G, Idahl A, Krogh V, Lukanova A, Marrangoni A, Muti P, Nolen BM, Ohlson N, Shore RE, Sieri S, Zeleniuch-Jacquotte A.

Cancer Causes Control. 2013 Apr;24(4):741-8. doi: 10.1007/s10552-013-0156-6. Epub 2013 Feb 3.

5.

Oxidants and not alkylating agents induce rapid mtDNA loss and mitochondrial dysfunction.

Furda AM, Marrangoni AM, Lokshin A, Van Houten B.

DNA Repair (Amst). 2012 Aug 1;11(8):684-92. doi: 10.1016/j.dnarep.2012.06.002. Epub 2012 Jul 4.

6.

Serum biomarker profiles as diagnostic tools in lung cancer.

Nolen BM, Langmead CJ, Choi S, Lomakin A, Marrangoni A, Bigbee WL, Weissfeld JL, Wilson DO, Dacic S, Siegfried JM, Lokshin AE.

Cancer Biomark. 2011-2012;10(1):3-12. doi: 10.3233/CBM-2012-0229.

7.

Factors associated with inflammation markers, a cross-sectional analysis.

Clendenen TV, Koenig KL, Arslan AA, Lukanova A, Berrino F, Gu Y, Hallmans G, Idahl A, Krogh V, Lokshin AE, Lundin E, Muti P, Marrangoni A, Nolen BM, Ohlson N, Shore RE, Sieri S, Zeleniuch-Jacquotte A.

Cytokine. 2011 Dec;56(3):769-78. doi: 10.1016/j.cyto.2011.09.013. Epub 2011 Oct 19.

8.

Circulating inflammation markers and risk of epithelial ovarian cancer.

Clendenen TV, Lundin E, Zeleniuch-Jacquotte A, Koenig KL, Berrino F, Lukanova A, Lokshin AE, Idahl A, Ohlson N, Hallmans G, Krogh V, Sieri S, Muti P, Marrangoni A, Nolen BM, Liu M, Shore RE, Arslan AA.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):799-810. doi: 10.1158/1055-9965.EPI-10-1180. Epub 2011 Apr 5.

9.

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.

Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC Jr, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, Ward DC, Symanowski JT, Lomakin A, Fung ET, Sluss PM, Scholler N, Lu KH, Marrangoni AM, Patriotis C, Srivastava S, Buys SS, Berg CD; PLCO Project Team.

Cancer Prev Res (Phila). 2011 Mar;4(3):375-83. doi: 10.1158/1940-6207.CAPR-10-0193.

10.

Temporal reliability of cytokines and growth factors in EDTA plasma.

Clendenen TV, Arslan AA, Lokshin AE, Idahl A, Hallmans G, Koenig KL, Marrangoni AM, Nolen BM, Ohlson N, Zeleniuch-Jacquotte A, Lundin E.

BMC Res Notes. 2010 Nov 13;3:302. doi: 10.1186/1756-0500-3-302.

11.

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.

Nolen B, Velikokhatnaya L, Marrangoni A, De Geest K, Lomakin A, Bast RC Jr, Lokshin A.

Gynecol Oncol. 2010 Jun;117(3):440-5. doi: 10.1016/j.ygyno.2010.02.005. Epub 2010 Mar 24.

12.

Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop.

Levina V, Marrangoni A, Wang T, Parikh S, Su Y, Herberman R, Lokshin A, Gorelik E.

Cancer Res. 2010 Jan 1;70(1):338-46. doi: 10.1158/0008-5472.CAN-09-1102. Epub 2009 Dec 22.

13.

Role of eotaxin-1 signaling in ovarian cancer.

Levina V, Nolen BM, Marrangoni AM, Cheng P, Marks JR, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE.

Clin Cancer Res. 2009 Apr 15;15(8):2647-56. doi: 10.1158/1078-0432.CCR-08-2024. Epub 2009 Apr 7.

14.

Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay.

Nolen B, Winans M, Marrangoni A, Lokshin A.

J Immunol Methods. 2009 May 31;344(2):116-20. doi: 10.1016/j.jim.2009.03.017. Epub 2009 Apr 5.

15.

Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases.

Linkov F, Ferris RL, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Gooding W, Nolan B, Winans M, Siegel ER, Lokshin A, Stack BC Jr.

Proteomics Clin Appl. 2008 Oct 10;2(12):1575-1585.

16.

Reproducibility of serum cytokines and growth factors.

Gu Y, Zeleniuch-Jacquotte A, Linkov F, Koenig KL, Liu M, Velikokhatnaya L, Shore RE, Marrangoni A, Toniolo P, Lokshin AE, Arslan AA.

Cytokine. 2009 Jan;45(1):44-9. doi: 10.1016/j.cyto.2008.10.014. Epub 2008 Dec 5.

17.

A serum based analysis of ovarian epithelial tumorigenesis.

Nolen B, Marrangoni A, Velikokhatnaya L, Prosser D, Winans M, Gorelik E, Lokshin A.

Gynecol Oncol. 2009 Jan;112(1):47-54. doi: 10.1016/j.ygyno.2008.09.043. Epub 2008 Nov 12.

18.

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties.

Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE.

PLoS One. 2008 Aug 27;3(8):e3077. doi: 10.1371/journal.pone.0003077.

19.

Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production.

Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE.

Exp Cell Res. 2008 Apr 15;314(7):1605-16. doi: 10.1016/j.yexcr.2007.12.027. Epub 2008 Jan 16.

20.

Reliability of tumor markers, chemokines, and metastasis-related molecules in serum.

Linkov F, Gu Y, Arslan AA, Liu M, Shore RE, Velikokhatnaya L, Koenig KL, Toniolo P, Marrangoni A, Yurkovetsky Z, Zeleniuch-Jacquotte A, Lokshin AE.

Eur Cytokine Netw. 2009 Mar;20(1):21-6. doi: 10.1684/ecn.2009.0146.

21.

Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin.

Yurkovetsky Z, Ta'asan S, Skates S, Rand A, Lomakin A, Linkov F, Marrangoni A, Velikokhatnaya L, Winans M, Gorelik E, Maxwell GL, Lu K, Lokshin A.

Gynecol Oncol. 2007 Oct;107(1):58-65. Epub 2007 Jul 19.

22.

Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.

Yurkovetsky ZR, Kirkwood JM, Edington HD, Marrangoni AM, Velikokhatnaya L, Winans MT, Gorelik E, Lokshin AE.

Clin Cancer Res. 2007 Apr 15;13(8):2422-8.

23.

Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.

Linkov F, Lisovich A, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Nolen B, Winans M, Bigbee W, Siegfried J, Lokshin A, Ferris RL.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):102-7.

24.

Multianalyte profiling of serum cytokines for detection of pancreatic cancer.

Zeh HJ, Winikoff S, Landsittel DP, Gorelik E, Marrangoni AM, Velikokhatnaya L, Winans MT, Lee K, Moser A, Bartlett D, Lotze MT, Siegfried JM, Whitcomb D, Papacristou G, Slivka A, Bigbee WL, Lokshin AE.

Cancer Biomark. 2005;1(6):259-69. Erratum in: Cancer Biomark. 2006;2(3-4):175. Papacristou, G [added].

PMID:
17192050
25.

Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer.

Lokshin AE, Winans M, Landsittel D, Marrangoni AM, Velikokhatnaya L, Modugno F, Nolen BM, Gorelik E.

Gynecol Oncol. 2006 Aug;102(2):244-51. Epub 2006 Jan 24.

PMID:
16434085
26.

Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer.

Gorelik E, Landsittel DP, Marrangoni AM, Modugno F, Velikokhatnaya L, Winans MT, Bigbee WL, Herberman RB, Lokshin AE.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):981-7.

27.

IL-12 receptor-mediated upregulation of FasL in human ovarian carcinoma cells.

Gorelik E, Edwards RP, Feng X, Marrangoni AM, Grandis JR, Drenning SD, Velikokhatnaya L, Kwon JA, Lokshin AE.

Int J Cancer. 2004 Nov 20;112(4):620-7.

28.

Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines.

Siervo-Sassi RR, Marrangoni AM, Feng X, Naoumova N, Winans M, Edwards RP, Lokshin A.

Cancer Lett. 2003 Feb 10;190(1):61-72.

PMID:
12536078
29.

Surgical management of entrapped percutaneous transluminal coronary angioplasty hardware.

Chang TM, Pellegrini D, Ostrovsky A, Marrangoni AG.

Tex Heart Inst J. 2002;29(4):329-32.

30.

Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class II.

Lokshin AE, Kalinski P, Sassi RR, Mailliard RB, Müller-Berghaus J, Storkus WJ, Peng X, Marrangoni AM, Edwards RP, Gorelik E.

Int Immunol. 2002 Sep;14(9):1027-37.

PMID:
12202400
31.

Fibrovascular lipoma of the cerebellopontine angle mimicking trigeminal neuralgia.

Behar PM, Dolan R, Dastur K, Marrangoni AG, Nayak N.

Ear Nose Throat J. 1998 Jan;77(1):58-60. No abstract available.

PMID:
9473835
32.

Right ventricular outflow obstruction with intact ventricular septum in adults.

Werner AM, Darrell JC, Pallegrini RV, Woelfel GF, Grant K, Marrangoni AG.

Tex Heart Inst J. 1997;24(2):105-8.

33.

Inhibition of experimental liver metastasis by combined treatment with tamoxifen and interferon.

Werner A, Bender E, Mahaffey W, McKeating J, Marrangoni A, Katoh A.

Anticancer Drugs. 1996 May;7(3):307-11.

PMID:
8792005
34.

Recurrent fibrovascular polyp of the esophagus.

Behar PM, Arena S, Marrangoni AG.

Am J Otolaryngol. 1995 May-Jun;16(3):209-12. No abstract available.

PMID:
7661321
35.

Recurrent ischemic heart disease: the effect of advancing age.

Pellegrini RV, Di Marco RF, Werner AM, Marrangoni AG.

J Cardiovasc Surg (Torino). 1994 Oct;35(5):371-6.

PMID:
7995826
36.

Advantages of laparoscopic cholecystectomy in the elderly and in patients with high ASA classifications.

Massie MT, Massie LB, Marrangoni AG, D'Amico FJ, Sell HW Jr.

J Laparoendosc Surg. 1993 Oct;3(5):467-76.

PMID:
8251661
37.

Normothermic retrograde continuous cardioplegia for myocardial protection during cardiopulmonary bypass. A modified technique.

Massie MT, Darrell JC, DiMarco RF, Marrangoni AG, Wei LM, Miller S, Woelfel GF, Pellegrini RV.

Tex Heart Inst J. 1993;20(2):89-93.

38.

Treatment of experimentally induced pancreatitis in ex vivo perfused canine pancreas with the somatostatin analogue octreotide.

Davliakos GP, Petraiuolo WJ, Sell HW Jr, Smith W, Marrangoni AG.

Curr Surg. 1990 Sep-Oct;47(5):343-5. No abstract available.

PMID:
1701696
39.

Management of blunt injury to the internal carotid artery.

Pellegrini RV, Marrangoni AG, DiMarco RF, Bekoe S.

J Trauma. 1988 Nov;28(11):1610. No abstract available.

PMID:
3184231
40.

Vascular grafts in microvascular surgery. An experimental study.

Marrangoni AG, Marcelli G, Culig M, Simone ST.

Am J Surg. 1988 Feb;155(2):258-62.

PMID:
3124653
41.

Contraindications for percutaneous transluminal coronary angioplasty in treatment of unstable angina pectoris.

Dimarco RF, McKeating JA, Pellegrini RV, Marrangoni AG, Bekoe S, Grant KJ, Woelfel GF.

Tex Heart Inst J. 1988;15(3):152-4.

42.

Swan-Ganz catheter induced pulmonary hemorrhage.

Pellegrini RV, Marcelli G, Di Marco RF, Bekoe S, Grant K, Marrangoni AG.

J Cardiovasc Surg (Torino). 1987 Nov-Dec;28(6):646-9.

PMID:
3667678
43.

Massive chylopericardium after coronary artery bypass surgery.

Pellegrini RV, Travers DJ, Marrangoni AG, DiMarco RF, Bekoe S, Grant KJ, Woelfel GF.

Tex Heart Inst J. 1987 Sep;14(3):318-20.

44.

An experimental study on long-length polytetrafluoroethylene microvascular grafts in rats.

Brearly W, Marcelli G, Simone ST, Marrangoni AG.

Curr Surg. 1987 May-Jun;44(3):207-10. No abstract available.

PMID:
3595202
45.

Blunt rupture of both atrioventricular valves.

Pellegrini RV, Copeland CE, DiMarco RF, Bekoe S, Grant K, Marrangoni AG, Culig M.

Ann Thorac Surg. 1986 Oct;42(4):471-2.

PMID:
3767519
46.

Traumatic aortic insufficiency after blunt chest trauma.

DiMarco RF, Cocco A, Pellegrini RV, Marrangoni AG, Bekoe S, Grant K.

Tex Heart Inst J. 1986 Sep;13(3):309-12.

47.

Myocardial revascularization combined with aortic valve replacement.

Pellegrini RV, Kowalsky T, Marrangoni AG, Dimarco RF, Bekoe S, Grant KJ.

Tex Heart Inst J. 1986 Sep;13(3):275-9.

48.

The effects of pressure and hepatocellular damage in biliary tract obstruction.

Hughes KS, Kowalsky TE, Copeland CE, Marrangoni AG, Turbiner EH.

Curr Surg. 1984 Jul-Aug;41(4):277-9. No abstract available.

PMID:
6541116
49.

Revascularization of the circumflex coronary artery in the atrioventricular groove.

Pellegrini RV, Marcelli G, Bekoe S, DiMarco RF Jr, Marrangoni AG.

Ann Thorac Surg. 1984 May;37(5):379-81.

PMID:
6712342
50.

Intrahepatic cholestasis as a cause of false-positive hepatobiliary scanning.

Hughes KS, Marrangoni AG, Thompson DR, Turbiner E.

Curr Surg. 1984 May-Jun;41(3):176-9. No abstract available.

PMID:
6540159

Supplemental Content

Loading ...
Support Center